Product Name | MF | CAS | Details |
---|
3,5-Dibenzyloxyacetophenone | C22H20O3 | 728924-18-7 | Details |
Ticagrelor Sulfone | C23H28F2N6O6S | 274693-39-9 | Details |
(1-Methyl-3-oxo-cyclobutyl)carbamic acid tert-butyl ester | C10H17NO3 | 1523617-99-3 | Details |
Sitagliptin Impurity C | C16H12F6N4O | 1675201-13-4 | Details |
(4-aminophenyl)(imino)methyl-lambda6-sulfanone | C7H10N2OS | 38764-51-1 | Details |
Terbutaline Impurity 4 | C22H22O3 | 476176-83-7 | Details |
(4-Aminopyridin-3-yl)dimethylphosphine oxide | C7H11N2OP | 2260937-83-3 | Details |
Quinuclidine-4-carboxylic acid | C8H13NO2 | 55022-88-3 | Details |
2,5-BISHYDROXYMETHYL TETRAHYDROFURAN | C6H12O3 | 104-80-3 | Details |
ATV-FX1 sodiuM salt | C33H34FN2NaO7 | 1315629-79-8 | Details |
Tolvaptan Impurity 7 | C26H26N2O3 | 1432725-23-9 | Details |
6-Quinoxalinamine, 5-(dimethylphosphinyl)- | C10H12N3OP | 2267330-75-4 | Details |
6-BENZYL-5,7-DIOXO-OCTAHYDROPYRROLO[3,4-B] PYRIDINE | C14H16N2O2 | 128740-13-6 | Details |
2(1H)-Pyridinone,4-(hydroxymethyl)-(9CI) | C6H7NO2 | 127838-58-8 | Details |
Atorvastatin Cyclic (Isopropyl) Impurity | C33H35FN2O7 | 873950-17-5 | Details |
3-Bromo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridine | C7H7BrN2 | 905273-36-1 | Details |
5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid | C10H9N3O2 | 956317-36-5 | Details |
4-AMinopyridazine hydrochloride | C4H6ClN3 | 1400764-35-3 | Details |
(S)-3-((tert-butoxycarbonyl)isopropylamino)-2-(4-chlorophenyl)propanoic acid | C17H24ClNO4 | 1001179-33-4 | Details |
Dexrazoxane imputity 2 | C11H18N4O5 | 120418-77-1 | Details |
Ethanone, 1-[3,5-bis(phenylmethoxy)phenyl]-2-[(1,1-dimethylethyl)(phenylmethyl)amino]-, sulfate (1:1) | C33H37NO7S | 52144-93-1 | Details |
TOPRAMEZONE | C16H17N3O5S | 210631-68-8 | Details |
Terbutaline dibromide impurity | Details |
ICRF 198 | C11H20N4O6 | 75459-34-6 | Details |
1,4-bis(2-hydroperoxypropan-2-yl)benzene | C12H18O4 | 3159-98-6 | Details |
2-(Pyrimidin-2-yl)acetonitrile | C6H5N3 | 1000564-45-3 | Details |
2,5-Furandicarboxylic acid, tetrahydro- | C6H8O5 | 6338-43-8 | Details |
5-Fluoropyrimidine-2-carboxylic acid | C5H3FN2O2 | 1196151-51-5 | Details |
2,5-Diazabicyclo[4.1.0]heptane-2-carboxylic Acid DiMethylethyl Ester | C10H18N2O2 | 1228675-18-0 | Details |
7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-amine | C15H22N2 | 2045894-03-7 | Details |
1-Cyclopropylpiperazine dihydrochloride | C7H16Cl2N2 | 139256-79-4 | Details |
4-Pyrimidinamine, 2-chloro-N-[3-(4-methoxyphenyl)-5-isoxazolyl]- | C14H11ClN4O2 | 2408588-57-6 | Details |
ethyl 3,5-bis(benzyloxy)benzoate | C23H22O4 | 50841-46-8 | Details |
Ethanone, 1-(3-pyridazinyl)- (9CI) | C6H6N2O | 1122-63-0 | Details |
Benzenesulfonamide | C6H7NO2S | 98-10-2 | Details |
2-Cyclobutylideneacetic acid | C6H8O2 | 25021-04-9 | Details |
Moxifloxacin Impurity 29 | C21H22FN3O5 | 1395056-41-3 | Details |
BO-264 | C18H19N5O3 | 2408648-20-2 | Details |
4-bromo-1H-pyrrolo[2,3-b]pyridine | C7H5BrN2 | 348640-06-2 | Details |
SYN-7-HYDROXY-2-BENZYL-2-AZABICYCLO[2.2.1]HEPTANE | C13H17NO | 312954-60-2 | Details |
Atorvastatin Cyclic Sodium Salt (Isopropyl) Impurity | C33H36FN2NaO7 | 1316291-19-6 | Details |
1-(5-Bromo-2-pyrimidinyl)ethane | C6H5BrN2O | 1189169-37-6 | Details |
2,5-Diazabicyclo[2.2.2]octane-3,6-dione | C6H8N2O2 | 1004-98-4 | Details |
Moxifloxacin Decarboxy Analog | C20H24FN3O2 | 1322062-57-6 | Details |
Dexrazoxane imputity 3 | C11H18N4O5 | 120418-76-0 | Details |
6-Boc-1-oxa-6-azaspiro[2.5]octane | C11H19NO3 | 147804-30-6 | Details |
terbutaline nitrogen oxide | Details |
(S,S)-6-BENZYL-OCTAHYDRO-PYRROLO[3,4-B]PYRIDINE DIHYDROCHLORIDE | C14H20N2 | 151213-39-7 | Details |
2-pyridazin-4-ylacetonitrile | C6H5N3 | 1142927-95-4 | Details |
X3609; S8048; D00PBX; rg7601; W-6008; Z-3166; | C45H50ClN7O7S | 1257044-40-8 | Details |
1-Boc-3,3-difluoro-4-hydroxypyrrolidine | C9H15F2NO3 | 1434141-81-7 | Details |
1-Pyrrolidinecarboxylic acid, 3,3-difluoro-4-(hydroxymethyl)-, phenylmethyl ester | C13H15F2NO3 | 174073-95-1 | Details |
L-IDURONIC ACID, SODIUM SALT | C6H10O7 | 2073-35-0 | Details |
Pyridazin-3-ylmethanol | C5H6N2O | 37444-46-5 | Details |
UT-34 | C15H12F4N4O2 | 2168525-92-4 | Details |
Tolvaptan dehydroxylated impurity | Details |
SUGAMMADEX | C72H112O48S8 | 343306-71-8 | Details |
6-Chloro-3-pyridazinecarboxaldehyde | C5H3ClN2O | 303085-53-2 | Details |
4-Chloro-5-Bromopyrimidine | C4H2BrClN2 | 56181-39-6 | Details |
exo-3-Boc-aminotropane | C12H22N2O2 | 132234-68-5 | Details |
ANTI-7-HYDROXY-2-BENZYL-2-AZABICYCLO[2.2.1]HEPTANE | C13H17NO | 745836-29-7 | Details |
2,5-Diaminohexanedioic acid | C6H12N2O4 | 1069-33-6 | Details |
7-(4-methylpiperazin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-3-amine | C16H25N3 | 1022959-01-8 | Details |
4-Amino-3-(dimethylphosphoryl)benzonitrile | C9H11N2OP | 2362003-67-4 | Details |
1-(4-Aminophenyl)phosphine 1-oxide | Details |
2,5-Diaminoadipic acid 2HCl | C6H13ClN2O4 | 52408-04-5 | Details |
6-Benzyl-5,7-dihydro-5,7-dioxopyrrolo[3,4-b]pyridine | C14H10N2O2 | 18184-75-3 | Details |
Hydrocortisone | C26H36O7 | 74050-20-7 | Details |
3-aminopyrazine-2-carbaldehyde | C5H5N3O | 32710-14-8 | Details |
(8aS)-Hexahydro-pyrrolo[1,2-a]pyrazin-6(2H)-one hydrochloride | C7H12N2O | 151763-88-1 | Details |
Atorvastatin Impurity | C26H22FNO4 | 148146-51-4 | Details |
3-Benzyl-7-oxo-3-aza-bicyclo[3.3.1nan-9-one | C14H17NO2 | 77716-01-9 | Details |
3-benzyl-3,6-diazabicyclo[3.1.1]heptane | C12H16N2 | 869494-14-4 | Details |
3,3-Dimethoxy-1-methyl-cyclobutanecarboxylic acid | C8H14O4 | 1408075-28-4 | Details |
Ethyl 1H-pyrazole-3-carboxylate | C6H8N2O2 | 5932-27-4 | Details |
Pyrimidine-5-carboxaldehyde | C5H4N2O | 10070-92-5 | Details |
1-[3,5-bis(phenylmethoxy)phenyl]-2-bromoethan-1-one | C22H19BrO3 | 28924-18-7 | Details |
1-Boc-3-methanesulfonyloxy-azetidine | C9H17NO5S | 141699-58-3 | Details |
Atorvastatin Impurity | C33H35FN2O7 | 873950-18-6 | Details |
(R)-2-Ami-2-(oxetan-3-yl)acetic acid | C5H9NO3 | 394653-43-1 | Details |
4-Chloro-2-(methylthio)pyrimidine-5-carbaldehyde | C6H5ClN2OS | 148256-82-0 | Details |
N-[(3R,4R)-4-fluoro-3-piperidinyl]-,1,1-dimethylethyl ester | C10H19FN2O2 | 1052713-46-8 | Details |
Methyl 3-(hydroxymethyl)cyclobutanecarboxylate | C7H12O3 | 89941-55-9 | Details |
5-Boc-octahydro-pyrrolo[3,4-c]pyridine | C12H22N2O2 | 1257389-94-8 | Details |
Sitagliptin Impurity D | C16H12F6N4O | 1675201-14-5 | Details |
trans-3,4-Dihydroxypyrrolidine hydrochloride | C4H10ClNO2 | 519188-72-8 | Details |
2-nitro-8,9-dihydro-5H-benzo[7]annulen-7(6H)-one | C11H11NO3 | 740842-50-6 | Details |
2-(Chloromethyl)pyrimidine | C5H5ClN2 | 54198-88-8 | Details |
4-(3-Bromophenyl)-9-phenyl-9H-carbazole | C24H16BrN | 2088030-59-3 | Details |
2-Piperidinecarboxylic acid, 5-amino-6-oxo-, ethyl ester | C8H14N2O3 | 915976-48-6 | Details |
5-Iodoquinoxalin-6-amine | C8H6IN3 | 2174002-51-6 | Details |
Hexanedioic acid, 2,5-bis[[(1,1-dimethylethoxy)carbonyl]amino]- (9CI) | C16H28N2O8 | 134143-68-3 | Details |
2,4-Diiodoaniline | C6H5I2N | 533-70-0 | Details |
Moxifloxacin impurity | C21H22FN3O4 | 2315304-27-7 | Details |
Benzenamine, 2-(S-methylsulfonimidoyl)- | C7H10N2OS | 67483-70-9 | Details |
Benzenamine, 3-(S-methylsulfonimidoyl)- | C7H10N2OS | 851008-24-7 | Details |
Benzenamine, 4-(tetrahydro-4-methyl-4-oxido-1,4-azaphosphorin-1(2H)-yl)- | C11H17N2OP | 2241226-28-6 | Details |
(2-Amino-5-fluorophenyl)dimethylphosphine oxide | C8H11FNOP | 1263178-53-5 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 |